Thursday, February 7, 2019

PMDA Japan : MHLW Pharmaceuticals and Medical Devices Safety Information on Nusinersen sodium, Axitinib, and Other Products Under Vigilance

Japanese version issued onNo.Table of contentsPosted onPDF
February 5,
2019
360
  1. Package Inserts of Prescription Drugs under the Revised Instructions
  2. Important Safety Information
  1. Revision of Precautions (No. 300)
    Nusinersen sodium (and 5 others)
  2. List of Products Subject to Early Post-marketing Phase Vigilance
Feb 5,
2019
(Full text)
年月日No.目次参考日本語版英語版
平成31年2月5日360
  1. 改正記載要領に基づく医療用医薬品添付文書について
  2. 重要な副作用等に関する情報
    【1】ヌシネルセンナトリウム
    【2】アキシチニブ
  3. 使用上の注意の改訂について(その300)
    ヌシネルセンナトリウム 他(5件)
  4. 市販直後調査の対象品目一覧
 PDF形式PDF形式

No comments:

GA

Make sure you know about all recalls & keep your family safe, Subscribe Free via email

Enter your email address Or Click on FeedBurner Icon (Right) to subscribe via Your News Reader. Your Email is never shared:

Delivered by FeedBurner